Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Tyrosine bioconjugation with hypervalent iodine
Nina
Declas
a,
John R. J.
Maynard
b,
Laure
Menin
c,
Natalia
Gasilova
c,
Sebastian
Götze
d,
Jakob L.
Sprague
e,
Pierre
Stallforth
d,
Stefan
Matile
b and
Jerome
Waser
*a
aLaboratory of Catalysis and Organic Synthesis, Institut des Sciences et Ingénierie Chimique, Ecole Polytechnique Fédérale de Lausanne, CH-1015, Lausanne, Switzerland. E-mail: jerome.waser@epfl.ch
bDepartment of Organic Chemistry, University of Geneva, 1211 Geneva, Switzerland. E-mail: stefan.matile@unige.ch
cInstitut des Sciences et Ingénierie Chimique, Ecole Polytechnique Fédérale de Lausanne, EPFL, 1015 Lausanne, Switzerland
dDepartment of Paleobiotechnology, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute (HKI), 07745 Jena, Germany
eDepartment of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute (HKI), 07745 Jena, Germany
First published on 15th December 2022
Abstract
Correction for ‘Tyrosine bioconjugation with hypervalent iodine’ by Nina Declas et al., Chem. Sci., 2022, 13, 12808–12817, https://doi.org/10.1039/D2SC04558C.
The authors regret that due to a technical issue with the ChemDraw file, part of the reaction conditions in Scheme 2 on page 12811 of the original article were not visible. A revised Scheme 2 with full reaction conditions is shown below:
 | ||
Scheme 2 (a) Scope of tetramers on 20.0 μmol. (b) Scope of bioactive peptides on 1.0 μmol or 1.0 mg. Tyr* = Tyr modified with EBX. HPLC-MS yields are given, determined as indicated in Scheme 1. aIsolated yield. bObtained as a 1![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) :2 mixture with 4. | ||
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2023 |